Barclays Upgrades Agilon Health (AGL)

Agilon Health, Inc. (NYSE:AGL) is one of the best small cap stocks to buy for the long term. Barclays upgraded Agilon Health, Inc. (NYSE:AGL) to Equal Weight from Underweight on May 26, setting a price target of $81 for the stock. The firm believes that the outlook for value-based care has “materially improved in recent weeks, driven by encouraging signs” of stabilizing cost trends and a more favorable 2027 Medicare Advantage rate outcome. It further told investors in a research note that the company’s fiscal Q1 report “significantly de-risks” forward estimates.

Agilon Health, Inc. (NYSE:AGL) also received a rating update from Benchmark on May 21, with the firm lifting the price target on the stock to $95 from $13 and reiterating a Buy rating on the shares. It stated that after a “remarkable” year-to-date performance, the firm thinks the current valuation “may restrain additional near-term performance”. However, Benchmark also believes that the company is in “the very early days of dramatic margin expansion with the potential for accelerating growth and longer-term stock performance.”

Agilon Health, Inc. (NYSE:AGL) provides healthcare services and is also involved in the provision of capital, payor relationships, data, executive experience, and contract support that allow physician groups to take on the risk of total care for their patients.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey on Google News.